newsfilter
← Latest News
GlobeNewswire·

Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

EXTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ("Idera," the "Company," "we," "us," or "our") (NASDAQ:IDRA) today reported its financial and operational results for the first quarter ended March 31, 2022. "We continue to pr